124 related articles for article (PubMed ID: 22772632)
1. Therapeutic plasma exchange as a crisis option in severe pemphigus vulgaris.
Ranugha PS; Kumari R; Kartha LB; Parameswaran S; Thappa DM
Indian J Dermatol Venereol Leprol; 2012; 78(4):508-10. PubMed ID: 22772632
[No Abstract] [Full Text] [Related]
2. A case of Sweet's syndrome and pemphigus vulgaris.
del Pozo J; Martínez W; Carro E; Arévalo MP; Rodríguez-Lozano J; Fonseca E
J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):745-6. PubMed ID: 15482319
[No Abstract] [Full Text] [Related]
3. [Pemphigus vulgaris--malignant course].
Steiner A; Diem E
Hautarzt; 1986 Sep; 37(9):499-502. PubMed ID: 3533847
[TBL] [Abstract][Full Text] [Related]
4. Verrucous plaques in a pemphigus vulgaris patient on immunosuppressive therapy.
Heng YK; Lee JS; Neoh CY
Int J Dermatol; 2012 Sep; 51(9):1044-6. PubMed ID: 22909356
[No Abstract] [Full Text] [Related]
5. Etiology of pyrexia in pemphigus patients: a dermatologist's enigma.
Qadim HH; Hasani A; Zinus BM; Orang NJ; Hasani A
Indian J Dermatol Venereol Leprol; 2012; 78(6):774. PubMed ID: 23075657
[No Abstract] [Full Text] [Related]
6. Treatment strategies for pemphigus vulgaris in Japan.
Hashimoto T
Expert Opin Pharmacother; 2008 Jun; 9(9):1519-30. PubMed ID: 18518782
[TBL] [Abstract][Full Text] [Related]
7. New and innovative interventions in the management of pemphigus.
Frydman AS; Fairley JA
G Ital Dermatol Venereol; 2011 Jun; 146(3):211-24. PubMed ID: 21566551
[TBL] [Abstract][Full Text] [Related]
8. The role of therapeutic plasma exchange in pemphigus vulgaris.
Sagi L; Baum S; Gendelman V; Trau H; Barzilai A
J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):82-6. PubMed ID: 20477926
[TBL] [Abstract][Full Text] [Related]
9. A novel therapeutic option in pemphigus vulgaris: humanized monoclonal anti-CD25 antibody.
Renkl A; Mockenhaupt M; Technau K; Herouy Y; Norgauer J
Br J Dermatol; 2004 Jun; 150(6):1220-2. PubMed ID: 15214921
[No Abstract] [Full Text] [Related]
10. Infective endocarditis due to Enterococcus faecalis manifesting as pemphigus foliaceus.
Ioannou P; Tsagkaraki E; Vamvoukaki R; Kouvidou C; Krasagakis K; Chamilos G; Gikas A
Hellenic J Cardiol; 2019; 60(3):202-204. PubMed ID: 30092274
[No Abstract] [Full Text] [Related]
11. Treatment of severe pemphigus vulgaris of the scalp with adjuvant rituximab and immunoadsorption.
Kamphausen I; Schulze F; Schmidt E; Zillikens D; Kunz M
Eur J Dermatol; 2012; 22(6):786-7. PubMed ID: 23114083
[No Abstract] [Full Text] [Related]
12. [A study on the therapy and prognosis of pemphigus vulgaris].
Yoshiike K; Shiozawa E; Yamada H; Taneda A; Takamori K; Ogawa H
Nihon Hifuka Gakkai Zasshi; 1990 Jun; 100(7):773-8. PubMed ID: 2214242
[TBL] [Abstract][Full Text] [Related]
13. Acanthosis nigricans developing in resolving lesions of pemphigus vulgaris.
Coverton RW; Armstrong RB
Arch Dermatol; 1982 Feb; 118(2):115-6. PubMed ID: 7059213
[No Abstract] [Full Text] [Related]
14. Chryseobacterium meningosepticum cellulitis and sepsis in an adult female with Pemphigus vulgaris.
Sood S; Nerurkar V; Malvankar S
Indian J Med Microbiol; 2010; 28(3):268-9. PubMed ID: 20644326
[No Abstract] [Full Text] [Related]
15. Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid.
Mazzi G; Raineri A; Zanolli FA; Da Ponte C; De Roia D; Santarossa L; Guerra R; Orazi BM
Transfus Apher Sci; 2003 Feb; 28(1):13-8. PubMed ID: 12620264
[TBL] [Abstract][Full Text] [Related]
16. Controlled study of plasma exchange in pemphigus.
Guillaume JC; Roujeau JC; Morel P; Doutre MS; Guillot B; Lambert D; Lauret P; Lorette G; Prigent F; Triller R
Arch Dermatol; 1988 Nov; 124(11):1659-63. PubMed ID: 3178248
[TBL] [Abstract][Full Text] [Related]
17. Oral pemphigus vulgaris in children and adolescents: a review of the literature and a case report.
Ariyawardana A; Tilakaratne WM; Dissanayake M; Vitanaarachchi N; Basnayake LK; Sitheeque MA; Ranasinghe AW
Int J Paediatr Dent; 2005 Jul; 15(4):287-93. PubMed ID: 16011788
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of pemphigus with plasmapheresis].
Friedman-Birnbaum R; Schechter Y; Bochner H
Harefuah; 1989 Sep; 117(5-6):135-7. PubMed ID: 2485756
[TBL] [Abstract][Full Text] [Related]
19. Intermittent plasmapheresis prevents recurrence in neuromyelitis optica.
Miyamoto K; Kusunoki S
Ther Apher Dial; 2009 Dec; 13(6):505-8. PubMed ID: 19954473
[TBL] [Abstract][Full Text] [Related]
20. The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris.
Turner MS; Sutton D; Sauder DN
J Am Acad Dermatol; 2000 Dec; 43(6):1058-64. PubMed ID: 11100023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
